1. Barefoot J.C., Helms M.J., Mark D.V. et al. Depression and long-term mortality risk in patients with coronary artery diseas // Am. J. Cardiol. - 1996. - Vol. 78. - P. 613-617.
2. Weisse C.S. Depression and immunocompetence, a review of the literature // Psych. Bull. - 1992. - Vol. 111. - P. 475-489.
3. Kronfol Z. Immune dysregulation in major depression: a critical review of exesting evidence // Int. J. Neuropsychopharmacol. - 2002. - Vol. 5. - P. 333-343.
4. Licinio J., Wong M.-L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems and contribute to neurotoxicity and neuroprotection // Mol. Psychiatr. - 1999. - Vol. 4. - P. 317-327.
5. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale // Acta Psychiatr. Scand. - 1983. - Vol. 67. - P. 361-370.
6. Hamilton M. Hamilton anxiety scale // In: Gue W. editors. ECDEU Assessment manual for psycholopharmacology: Rev. Ed. Washington DC: US Department of Health, Education and Welfare. - 1976. - P. 193-198.
7. Hamilton M. A rating for depression // J. Neurol. Neurosurg. Psychiatr. - 1960. - Vol. 23. - P. 56-61.
8. Maes M. Evidence for an immune response in major depression: a review and hypothesis // Prog. Neuropsychopharmacol. Biol. Psychiatr. - 1995. - Vol. 19. - P. 11-38.
9. Lieb J., Karmali R., Horrobin D. Elevated levels of prostaglandin E2 and thromboxane B2 in depression // Prostaglandins Leukotrience Med. - 1983. - Vol. 10. - P. 361-367.
10. Kronfol Z., House J.D. Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls // Acta Psychiatr. Scand. - 1989. - Vol. 80. - P. 142-147.
11. Smith R.S. The macrophage theory of depression // Med Hypothesis. - 1991. - Vol. 35. - P. 298-306.
12. Maes M., Lambrechts J., Bosmans E. et al. Evidence for a systemic immune activation during depression, results of leucocyte enumeration by flow cytometry in conjunction with monoclonal antiboby staining // Psychol. Med. - 1992. - Vol. 22. - P. 45-53.
13. Duch D.S., Woolf J.H., Nichol C. Urinary exretion of biopterin and neopterin in psychiatric disorders // Psychiatr. Res. - 1984. - Vol. 11. - P. 83-89.
14. Landmann R., Schaub B., Link S. et al. Unaltered monocyte function in patients with major depression before and after tree months of antidepressive therapy // Biol. Psychiatr. - 1999. - Vol. 15. - P. 675-681.
15. Natelson B.N., Denny T., Zhou X.D. et al. Is depression associated with immune activation? // J. Affect. Disorders. - 1999. - Vol. 53. - P. 179-184.
16. Dicknes C., McGowan L., Clark-Carter D. et al. Depression in rheumatoid arthritis, a systematic review of the literature with meta-analysis // Psychosom. Med. - 2002. - Vol. 64. - P. 52-60.
17. Marshall P.S. Allergy and depression, a neurochemical threshold model of the relation between the illnesses // Psychol. Bull. - 1993. - Vol. 113. - P. 23-24.
18. Minden S.L., Schiffer R.B. Affective disorders in multiple sclerosis: Review and recommendations for clinical research // Acch. Neurol. - 1990. - Vol. 47. - P. 98-104.
19. Pollmacher T., Haack M., Schuld A. et al. Low levels of circulating inflammatory cytokines - do they affect human brain functions? // Brain Behav. Immun. - 2002. - Vol. 16. - P. 525-532.
20. Griffiths J., Ravindran A.V., Merali Z. et al. Neuroendocrine measures and lymphocyte subsets in depressive illness: influence of a clinical interview concerning life experiences // Psychoneuroendocrinology - 1997. - Vol. 22. - P. 225-236.
21. Owen B.M., Eccleston D., Ferrier I.N. et al. Raised levels of plasma interleukin-1β in major and postviral depression // Acta Psychiatr. Scand. - 2001. - Vol. 103. - P. 226-228.
22. Brambilla F., Maggioni M. Blood levels of cytokines in elderly patients with major depressive disorder // Acta Psychiatr. Scand. - 1998. - Vol. 97. - P. 309-313.
23. Levine J., Barak V., Chegappa K.N. et al. Cerebrospinal cytokine levels in patients with acute depression // Neuropsychobiology. - 1999. - Vol. 40. - P. 171-176.
24. Kent S., Bluthe R.-M., Kelley K.W. et al. Reduction in food and water intake induced by microinjection of interleukin-1β in the ventromedical hypothalamus of the rat // Physiol. Behav. - 1994. - Vol. 56. - P. 1031-1036.
25. Besedovsky H.O., delRay A., Sorkin A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones // Science. - 1986. - Vol. 233. - P. 652-654.
26. Silvermann M.N., Pearse B.D., Miller A.H. Cytokines and HPA axis regulation / In: Kronfol Z. Editor. Cytokines and Mental Health, Kluwer, Norvell, Maas. - 2003. - P. 85-122.
27. Strohle A, Holsboer F. Stress responsive neurohormones in depression and anxiety // Pharmacopsychiatry. - 2003. - Vol. 36. - P. S207-S214.
28. Coppen A., Wood K. Triptophan and depressive illness // Psychol. Med. - 1978. - Vol. 8. - P. 49-57.
29. Whooley M.A., Caska C.M., Hendrickson B.E. et al. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul study // Biol. Psychiatry. - 2007. - Vol. 62. - P. 314-320.
30. Mosovich S.A., Boone R.T., Reichenberg A. New insights into the link between cardiovascular disease and depression // Int. J. Clin. Pract. - 2008. - Vol. 62. - P. 423-432.
31. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour:mechanisms and implications // Trends Neurosci. - 2002. - Vol. 25. - P. 154-159.
32. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter // Clin. Chem. - 1994. - Vol. 40. - P. 288-295.
33. McAdam W. Aspirin / In: Cohen M. ed. Handbook of Antiplatelet Therapy. - London: Martin Dunitz, 2003. - P. 71-95.
34. Sheline Y.I., Bardgett M.E., Jackson J.L. et al. Platelet serotonin markers and depressive symptomatology // Biol. Psychiatry. - 1995. - Vol. 37. - P. 442-447.
35. Hardardottir I., Grunfeld C., Feingold K.R. Effects of endotoxin and cytokines on lipid metabolism // Curr. Opin. Lipidol. - 1994. - Vol. 5. - P. 207-215.
